Brief: China Nt Pharma Group Sees A Significant Increase In Revenue By About 25% For Six Months
27/08/2021 12:38
Aug 27 (Reuters) - China NT Pharma Group Company Ltd
1011.HK :
* SEES A SIGNIFICANT INCREASE IN REVENUE BY ABOUT 25% FOR
SIX
MONTHS
* SEES A SIGNIFICANT DECREASE IN NET LOSS BY ABOUT 80% FOR
SIX
MONTHS
* EXPECTES INCREASE IN REVENUE DUE TO INCREASE IN DEMAND
FROM
RECOVERY OF MARKET
* EXPECTED DECREASE IN NET LOSS DUE TO INCREASE IN GROSS
PROFIT
AND GAIN ON DISPOSAL OF A SUBSIDIARY DURING PERIOD
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma Co
See all newsBrief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY
Brief: China NT Pharma Makes Application For Resumption Of Trading On Feb 11
Brief: HKEX Says Trading In Shares Of China NT Pharma Group Company Halted
Brief: China Nt Pharma Group Says To Issue Bonds In Aggregate Principal Amount Of HK$65 Million